FONT-SIZE Plus   Neg

Coronado Biosciences Prices Public Offering Of 5 Mln Shares At $5.00/shr

Coronado Biosciences Inc. (CNDO) announced the pricing of its underwritten public offering of 5 million shares of its common stock at a price to the public of $5.00 per share for gross proceeds to Coronado of $25.0 million.

Coronado said it expects to receive approximately $23.0 million in net proceeds from the offering, after deducting underwriting discount and estimated offering expenses.

The company also has granted the underwriters a 30-day option to purchase up to an aggregate of 750,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on June 27, 2012, subject to customary closing conditions.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
It looks like 2016 is going to be a relatively lackluster year in terms of new drug approvals. Only 18 new molecular entity drugs have been approved year-to-date compared to 32 approved during the same time frame last year. Apple Inc. plans to launch a new guide for Apple TV during a product event in California today, according to Recode. While major video partners have signed up to be a part of the new Apple TV guide, Netflix Inc. will reportedly not be participating. Wal-Mart Stores Inc. is gearing up for the upcoming holiday season by deploying an army of Holiday Helpers to help customers get through the checkout process faster during the busy period. The retailer has also increased the amount of products available through its Pickup service, lowered the price on thousand of items, and plans to expand the online assortment in the coming months.
comments powered by Disqus
Follow RTT